The epidemiologic relationship between tuberculosis and nontuberculous mycobacterial disease: A systematic review

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 11, 2014, Pages 1370-1377

  Brode, S K ^a,b,c   Daley, C L ^d,e   Marras, T K ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b WEST PARK HEALTHCARE CENTRE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d DEPARTMENT OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Mycobacterial infections; NTM; Tuberculosis

Indexed keywords

HEALTH; HUMAN; INCIDENCE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS;

GLOBAL HEALTH; HUMANS; INCIDENCE; LINEAR MODELS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; TUBERCULOSIS;

EID: 84908671959     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0120     Document Type: Review

References (47)

1. Dasgupta K, Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur Respir J 2005; 25: 1107-1116.
2. Marras T K, Daley C L. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002; 23: 553-567.
3. Al-Houqani M, Jamieson F, Mehta M, Chedore P, May K, Marras T K. Aging, COPD, and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario. Chest 2012; 141: 190-197.
4. Griffith D E, Aksamit T, Brown-Elliott B A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
5. Marras T K, Mehta M, Chedore P, May K, Al Houqani M, Jamieson F. Non-tuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung 2010; 188: 289-299.
6. Prevots D R, Shaw P A, Strickland D, et al. Non-tuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010; 182: 970-976.
7. Winthrop K L, McNelley E, Kendall B, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010; 182: 977-982.
8. Andrejak C, Thomsen VO, Johansen I S, et al. Non-tuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010; 181: 514-521.
9. O'Brien D P, Currie B J, Krause V L. Non-tuberculous mycobacterial disease in northern Australia: a case series and review of the literature. Clin Infect Dis 2000; 31: 958-967.
10. Robakiewicz M, Grzybowski S. Epidemiologic aspects of nontuberculous mycobacterial disease and of tuberculosis in British Columbia. Am Rev Respir Dis 1974; 109: 613-620.
11. Isaac-Renton J L, Allen E A, Chao C W, Grzybowski S, Whittaker E I, Black WA. Isolation and geographic distribution of Mycobacterium other than M. tuberculosis in British Columbia, 1972-81. CMAJ 1985; 133: 573-576.
12. Enarson D A, Wang J S, Dirks J M. The incidence of active tuberculosis in a large urban area. Am J Epidemiol 1989; 129: 1268-1276.
13. Ahn C H, Lowell J R, Onstad G D, Shuford E H, Hurst G A. A demographic study of disease due to Mycobacterium kansasii or M. intracellulare-avium in Texas. Chest 1979; 75: 120-125.
14. Jenkins P A. The epidemiology of opportunist mycobacterial infections in Wales, 1952-1978. Rev Infect Dis 1981; 3: 1021-1023.
15. Yates M D, Grange J M, Collins C H. The nature of mycobacterial disease in south east England, 1977-84. J Epidemiol Community Health 1986; 40: 295-300.
16. Debrunner M, Salfinger M, Brandli O, von Graevenitz A. Epidemiology and clinical significance of non-tuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 1992; 15: 330-345.
17. Kennedy M P, O'Connor T M, Ryan C, Sheehan S, Cryan B, Bredin C. Non-tuberculous mycobacteria: incidence in Southwest Ireland from 1987 to 2000. Respir Med 2003; 97: 257-263.
18. Henry M T, Inamdar L, O'Riordain D, Schweiger M, Watson J P. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 2004; 23: 741-746.
19. Gitti Z, Mantadakis E, Maraki S, Samonis G. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. Future Microbiol 2011; 6: 1099-1109.
20. Edwards F G. Disease caused by 'atypical' (opportunist) mycobacteria: a whole population review. Tubercle 1970; 51: 285-295.
21. Pang S C. Mycobacterium kansasii infections in Western Australia (1962-1987). Respir Med 1991; 85: 213-218.
22. Thomson R M. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010; 16: 1576-1583.
23. Sweeny A, Beard F. Queensland health notifiable diseases report 2002-2006. Brisbane, QLD, Australia: Communicable Diseases Branch, 2009.
24. Haverkort F. National atypical mycobacteria survey, 2000. Commun Dis Intell 2003; 27: 180-189.
25. Gilroy N. Tuberculosis notifications in Australia, 1997. National TB Advisory Group. Communicable Disease Network Australia and New Zealand. Commun Dis Intell 1999; 23: 337-348.
26. Lin M, Spencer J, Roche P, McKinnon M. Tuberculosis notifications in Australia, 2000. Commun Dis Intell 2002; 26: 214-225.
27. Public Health Agency of Canada. Tuberculosis in Canada 2009: pre-release. Ottawa, ON, Canada, 2010. http://www.phacaspc. gc.ca/tbpc-latb/pubs/tbcan09pre/pdf/tbcan2009pre-eng. pdf. Accessed August 2014.
28. Hernandez-Garduño E, Rodrigues M, Elwood R K. The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada. Int J Tuberc Lung Dis 2009; 13: 1086-1093.
29. Kubin M, Svandova E, Medek B, Chobot S, Olsovsky Z. Mycobacterium kansasii infection in an endemic area of Czechoslovakia. Tubercle 1980; 61: 207-212.
30. Andrejak C, Thomsen V O, Johansen I S, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010; 181: 514-521.
31. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of non-tuberculous mycobacteriosis in Japan. Am Rev Respir Dis 1988; 137: 1280-1284.
32. Sakatani M. [Epidemiology of non-tuberculous mycobacteriosis (NTM) in Japan]. Nihon Kyobu Shikkan Gakkai Zasshi 1994; 32 (Suppl): S211-S215. [Japanese]
33. Sakatani M. [Non-tuberculous mycobacteriosis (NTM) in Japan: epidemiologic and clinical study]. Kekkaku 1994; 69: 119-124. [Japanese]
34. Sakatani M. [Non-tuberculous mycobacteriosis; the present status of epidemiology and clinical studies]. Kekkaku 1999; 74: 377-384. [Japanese]
35. Khan K, Wang J, Marras T K. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 2007; 176: 306-313.
36. Katila ML, Brander E, Backman A. Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood. Tubercle 1987; 68: 291-296.
37. Romanus V, Hallander H O, Wahlen P, Olinder-Nielsen A M, Magnusson P H, Juhlin I. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tubercle Lung Dis 1995; 76: 300-310.
38. Trnka L, Dankova D, Svandova E. Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tubercle Lung Dis 1994; 75: 348-352.
39. Halverson J, Ellis E, Gallant V, Archibald C. Chapter 1: Epidemiology of tuberculosis in Canada. In: Menzies D, ed. Canadian tuberculosis standards. 7th ed. Ottawa, ON, Canada: Canadian Thoracic Society and The Public Health Agency of Canada, 2013.
40. Adjemian J, Olivier K N, Seitz A E, Holland S M, Prevots D R. Prevalence of nontuberculous mycobacterial lung disease in US Medicare beneficiaries. Am J Respir Crit Care Med 2012; 185: 881-886.
41. Dirac MA, Horan K L, Doody D R, et al. Environment or host? A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012; 186: 684-691.
42. Fowler C J, Olivier KN, Leung JM, et al. Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary non-tuberculous mycobacterial disease epithelium. Am J Respir Crit Care Med 2013; 187: 1374-1381.
43. Wilson L G. The historical decline of tuberculosis in Europe and America: its causes and significance. J Hist Med Allied Sci 1990; 45: 366-396.
44. Falkinham J O, 3rd. Non-tuberculous mycobacteria in the environment. Clin Chest Med 2002; 23: 529-551.
45. Marras T K, Wallace R J, Jr, Koth L L, Stulbarg MS, Cowl C T, Daley C L. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 2005; 127: 664-671.
46. Falkinham J O, 3rd, Iseman M D, de Haas P, van Soolingen D. Mycobacterium avium in a shower linked to pulmonary disease. J Water Health 2008; 6: 209-213.
47. Ohkusu K, Bermudez L E, Nash K A, MacGregor R R, Inderlied C B. Differential virulence of Mycobacterium avium strains isolated from HIV-infected patients with disseminated M. avium complex disease. J Infect Dis 2004; 190: 1347-1354.